Cargando…

Corticosteroid-Responsive Pulmonary Toxicity Associated with Fludarabine Monophosphate: A Case Report

Fludarabine monophosphate is an effective drug for the treatment of lymphoid malignancies. Myelosuppression, opportunistic infections, and autoimmune hemolytic anemia are the most common side effects of fludarabine. Herein we report a 55-year-old female that presented with fever and dyspnea after co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudzianskiene, Milda, Griniute, Rasa, Juozaityte, Elona, Inciura, Arturas, Rudzianskas, Viktoras, Emilia Kiavialaitis, Greta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781631/ https://www.ncbi.nlm.nih.gov/pubmed/24385727 http://dx.doi.org/10.5505/tjh.2012.50490

Ejemplares similares

Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study
por: Rudzianskiene, Milda, et al.
Publicado: (2017)

Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck
por: Rudžianskas, Viktoras, et al.
Publicado: (2018)

Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
por: Žilienė, Eglė, et al.
Publicado: (2023)

Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy
por: RUDZIANSKAS, V., et al.
Publicado: (2012)

Association of angiogenesis and inflammation-related gene functional polymorphisms with early-stage breast cancer prognosis
por: Korobeinikova, Erika, et al.
Publicado: (2020)

Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach
por: Kupcinskaite-Noreikiene, Rita, et al.
Publicado: (2016)

Mitochondria-Related TFAM and POLG Gene Variants and Associations with Tumor Characteristics and Patient Survival in Head and Neck Cancer
por: Golubickaite, Ieva, et al.
Publicado: (2023)

Mitochondria-related TFAM gene variants and their effects on patients with cervical cancer
por: Golubickaite, Ieva, et al.
Publicado: (2021)

POLG Gene Variants in Cervical Cancer Patients and Their Associations with Clinical and Pathomorphological Tumor Characteristics
por: Golubickaite, Ieva, et al.
Publicado: (2021)

TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2022)

Duffy and Kidd Genotyping Facilitates Pretransfusion Testing in Patients Undergoing Long-Term Transfusion Therapy
por: Remeikiene, Diana, et al.
Publicado: (2014)

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients
por: Inciura, Arturas, et al.
Publicado: (2006)

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
por: Dambrauskienė, Rūta, et al.
Publicado: (2023)

Development of a Model Based on Delta-Radiomic Features for the Optimization of Head and Neck Squamous Cell Carcinoma Patient Treatment
por: Šedienė, Severina, et al.
Publicado: (2023)

siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line
por: Savukaitytė, Aistė, et al.
Publicado: (2021)

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study
por: Jenciūtė, Gabrielė, et al.
Publicado: (2023)

The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy after Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study
por: Šedienė, Severina, et al.
Publicado: (2018)

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
por: Liutkauskiene, Sigita, et al.
Publicado: (2015)

Systemic Optimization of Gene Electrotransfer Protocol Using Hard-to-Transfect UT-7 Cell Line as a Model
por: Vadeikienė, Roberta, et al.
Publicado: (2022)

DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells
por: Savukaitytė, Aistė, et al.
Publicado: (2023)

Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patients
por: Savukaitytė, Aistė, et al.
Publicado: (2015)

The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients
por: Korobeinikova, Erika, et al.
Publicado: (2015)

Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
por: Bartnykaitė, Agnė, et al.
Publicado: (2021)

The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2021)

Application of 3D Gel Dosimetry as a Quality Assurance Tool in Functional Leksell Gamma Knife Radiosurgery
por: Kudrevicius, Linas, et al.
Publicado: (2022)

The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
por: Bartnykaitė, Agnė, et al.
Publicado: (2022)

Neurological illness following treatment with fludarabine.
por: Johnson, P. W., et al.
Publicado: (1994)

[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
por: Versluijs, A. Birgitta, et al.
Publicado: (2022)

Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience
por: Dambrauskiene, Ruta, et al.
Publicado: (2015)

Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study
por: Dambrauskienė, R, et al.
Publicado: (2017)

Cardiovascular response to bouts of exercise with blood flow restriction
por: Bunevicius, Kestutis, et al.
Publicado: (2016)

Animal Hen1 2′-O-methyltransferases as tools for 3′-terminal functionalization and labelling of single-stranded RNAs
por: Mickutė, Milda, et al.
Publicado: (2018)

Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
por: Whelan, J. S., et al.
Publicado: (1991)

Fludarabine in the treatment of chronic lymphocytic leukemia: a review
por: Ricci, Francesca, et al.
Publicado: (2009)

Low-grade lymphoma: Beyond fludarabine-single therapy
por: Park, Eunkyung
Publicado: (2011)

Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
por: Janssens, Ann, et al.
Publicado: (2009)

Fludarabine-induced bradycardia in a patient with refractory leukemia
por: Chung-Lo, Woei, et al.
Publicado: (2010)

Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies
por: Hirabayashi, Koichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5cu8rfvtc482t3ooei59vu34me